Clinical challenges of tissue preparation for spatial transcriptome

• Published in: Clinical and translational medicine Vol. 12; no. 1; pp. e669 - n/a
• Main Authors: Liu, Xiaoxia, Jiang, Yujia, Song, Dongli, Zhang, Linlin, Xu, Guang, Hou, Rui, Zhang, Yong, Chen, Jian, Cheng, Yunfeng, Liu, Longqi, Xu, Xun, Chen, Gang, Wu, Duojiao, Chen, Tianxiang, Chen, Ao, Wang, Xiangdong
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.01.2022; John Wiley and Sons Inc; Wiley
• Subjects: Biopsy; clinical challenge; Clinical medicine; critical factor; Electrocardiography; Enzymes; Experiments; Gene expression; Gene Expression Profiling - instrumentation; Gene Expression Profiling - methods; Humans; Interdisciplinary subjects; Lung cancer; Medicine; Nitrogen; Pathology; Quality control; spatial transcriptomics; spatiotemporal molecular image; spatiotemporal molecular medicine; Specimen Handling - methods; Specimen Handling - trends; Tomography; Beijing China; United States > US; China; Germany; clinical challenge; spatiotemporal molecular medicine; critical factor; spatial transcriptomics; spatiotemporal molecular image
• ISSN: 2001-1326; 2001-1326
• DOI: 10.1002/ctm2.669

Spatial transcriptomics is considered as an important part of spatiotemporal molecular images to bridge molecular information with clinical images. Of those potentials and opportunities, the excellent quality of human sample preparation and handling will ensure the precise and reliable information generated from clinical spatial transcriptome. The present study aims at defining potential factors that might influence the quality of spatial transcriptomics in lung cancer, para‐cancer, or normal tissues, pathological images of sections and the RNA integrity before spatial transcriptome sequencing. We categorised potential influencing factors from clinical aspects, including patient selection, pathological definition, surgical types, sample harvest, temporary preservation conditions and solutions, frozen approaches, transport and storage conditions and duration. We emphasis on the relationship between the combination of histological scores with RNA integrity number (RIN) and the unique molecular identifier (UMI), which is determines the quality of of spatial transcriptomics; however, we did not find significantly relevance between them. Our results showed that isolated times and dry conditions of sample are critical for the UMI and the quality of spatial transcriptomic samples. Thus, clinical procedures of sample preparation should be furthermore optimised and standardised as new standards of operation performance for clinical spatial transcriptome. Our data suggested that the temporary preservation time and condition of samples at operation room should be within 30 min and in ‘dry’ status. The direct cryo‐preservation within OCT media for human lung sample is recommended. Thus, we believe that clinical spatial transcriptome will be a decisive approach and bridge in the development of spatiotemporal molecular images and provide new insights for understanding molecular mechanisms of diseases at multi‐orientations. Processes and workflow of clinical spatial transcriptome from sample harvest to transcriptomic imprints.